Palatin Technologies Inc

Palatin Technologies: biopharma innovator tackling sexual dysfunction, heart failure, obesity—R&D focus, market rebound, and future‑growth potential.

Palatin Technologies Inc. has announced significant financial and research developments, including an expected $11.5 million financing and promising preclinical data for its glaucoma treatment, PL9588.